EVOQ Remedies Ltd.
Snapshot View

13.99 +0.49 ▲3.6%

24 June 2022, 04:01:00 PM
Volume: 4,000

Overview View Details

Sector Trading Compare with Sector peers
Industry Trading Compare with Industry peers
Website http://www.evoqremedies.com
Market Cap 19.03 Cr.
Enterprise Value(EV) 19.00 Cr. 2021-03
Financial Indicators
Earnings per share (EPS) 0.80 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 17.44 Trailing Twelve Months Ending 2022-03
Industry PE 127.06 Trailing Twelve Months Ending 2022-03
Book Value / Share 16.74 Trailing Twelve Months Ending 2022-03
Price to Book Value 0.84 Calculated using Price: 13.99
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 1.36 Cr. 13,600,000 Shares
FaceValue 10
Company Profile
No Company Profile found.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+3.63%
1 Week
+3.94%
1 Month
-2.30%
3 Month
6 Month
1 Year
2 Year
5 Year
10 Year
3 years 2019-03 2020-03 2021-03
Return on Equity (%) 49.78 1.34 188.09
Return on Capital Employed (%) 68.94 2.69 247.43
Return on Assets (%) 0.52 0.01 10.42

Balance Sheet View Details

Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Shh. Funds 0 0 1
Non Curr. Liab. 0 0
Curr. Liab. 2 6 7
Minority Int.
Equity & Liab. 2 6 8
Non Curr. Assets
Curr. Assets 2 6 8
Misc. Exp. not W/O
Total Assets 2 6 8

Profit Loss View Details

Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Net Sales 3 9 10
Other Income
Total Income 3 9 10
Total Expenditure -3 -9 -9
PBIDT 0 1
Interest
Depreciation
Taxation 0
Exceptional Items
PAT 0 1
Adjusted EPS

Cash Flow View Details

Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0
Cash Fr. Inv.
Cash Fr. Finan.
Net Change 0 0 0
Cash & Cash Eqvt 0 0

Shareholding Pattern View Details

1 Qtrs 2022-03 (%)
Promoter 73.53
Public 26.47
Depository Receipts 0.00
Promoter Holding Pledge (%) 0.00

Announcements View Details

Mon, 30 May 2022
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. On 30Th May 2022
Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company in their meeting held today i.e. on 30th May 2022 at the Registered Office of the Company which commenced at 12:00 P.M. and concluded at 3:40 P.M. has considered and approved Audited Financial Results for the Quarter and Financial Year ended on 31st March 2022 along with Auditors Report and Declaration.Kindly take same on your record and oblige us.Thanking You.Yours Faithfully For Evoq Remedies LimitedBhumishth PatelManaging DirectorDIN: 02516641
Mon, 30 May 2022
Submission Of Audited Financial Results For The Quarter And Year On31St March 2022 Along With Auditor'S Report And Declaration
In reference to captioned subject and pursuant to Regulation 33(3) (d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are hereby submitting the Audited Financial Results for the Quarter and Year ended on 31st March 2022 along with Auditors Report and Declaration.Kindly take same on your record and oblige us.Thanking You.Yours Faithfully For Evoq Remedies LimitedBhumishth PatelManaging DirectorDIN: 02516641
Mon, 30 May 2022
Submission Of Audited Financial Results For The Quarter And Year On<BR> 31St March 2022 Along With Auditor'S Report And Declaration<BR>
In reference to captioned subject and pursuant to Regulation 33(3) (d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are hereby submitting the Audited Financial Results for the Quarter and Year ended on 31st March 2022 along with Auditors Report and Declaration.

Kindly take same on your record and oblige us.

Thanking You.

Yours Faithfully

For Evoq Remedies Limited



Bhumishth Patel
Managing Director
DIN: 02516641

Technical Scans View Details

Fri, 24 Jun 2022
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Opening at Low Opening at Low
Opening at Low for 3 days Opening at Low for 3 days
Closing Above Previous High Closing Above Previous High

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. 246,411.24 2,161.50 +2.5%
Redington (India) Ltd. 9,522.15 121.85 +5.0%
MMTC Ltd. 5,962.50 39.75 +16.2%
Optiemus Infracom Ltd. 2,565.84 299.00 +10.7%
Polo Queen Industrial & Fintech Ltd. 1,608.24 47.90 +0.5%
SIRCA Paints India Ltd. 1,203.46 439.15 -0.5%
Shankar Lal Rampal Dye-Chem Ltd. 1,075.71 504.50 +3.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-03 317.31 2,161.50 +2.5%
Redington (India) Ltd. Consolidated 2022-03 7.44 121.85 +5.0%
MMTC Ltd. Consolidated 2021-12 0.00 39.75 +16.2%
Optiemus Infracom Ltd. Consolidated 2022-03 0.00 299.00 +10.7%
Polo Queen Industrial & Fintech Ltd. Consolidated 2022-03 0.00 47.90 +0.5%
SIRCA Paints India Ltd. Consolidated 2022-03 43.41 439.15 -0.5%
Shankar Lal Rampal Dye-Chem Ltd. Standalone 2022-03 39.75 504.50 +3.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-03 8.23 2,161.50 +2.5%
Redington (India) Ltd. Consolidated 2022-03 1.65 121.85 +5.0%
MMTC Ltd. Consolidated 2021-12 -20.80 39.75 +16.2%
Optiemus Infracom Ltd. Consolidated 2022-03 7.77 299.00 +10.7%
Polo Queen Industrial & Fintech Ltd. Consolidated 2022-03 10.00 47.90 +0.5%
SIRCA Paints India Ltd. Consolidated 2022-03 5.35 439.15 -0.5%
Shankar Lal Rampal Dye-Chem Ltd. Standalone 2022-03 14.01 504.50 +3.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 0.93 2,161.50 +2.5%
Redington (India) Ltd. Consolidated 2021-03 0.09 121.85 +5.0%
MMTC Ltd. Consolidated 2021-03 24.24 39.75 +16.2%
Optiemus Infracom Ltd. Consolidated 2021-03 0.31 299.00 +10.7%
Polo Queen Industrial & Fintech Ltd. Consolidated 2021-03 0.10 47.90 +0.5%
SIRCA Paints India Ltd. Consolidated 2021-03 0.07 439.15 -0.5%
Shankar Lal Rampal Dye-Chem Ltd. Standalone 2021-03 0.25 504.50 +3.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 4.38 2,161.50 +2.5%
Redington (India) Ltd. Consolidated 2021-03 17.02 121.85 +5.0%
MMTC Ltd. Consolidated 2021-03 -160.71 39.75 +16.2%
Optiemus Infracom Ltd. Consolidated 2021-03 30.53 299.00 +10.7%
Polo Queen Industrial & Fintech Ltd. Consolidated 2021-03 0.21 47.90 +0.5%
SIRCA Paints India Ltd. Consolidated 2021-03 8.59 439.15 -0.5%
Shankar Lal Rampal Dye-Chem Ltd. Standalone 2021-03 16.58 504.50 +3.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 4.38 2,161.50 +2.5%
Redington (India) Ltd. Consolidated 2021-03 17.02 121.85 +5.0%
MMTC Ltd. Consolidated 2021-03 -160.71 39.75 +16.2%
Optiemus Infracom Ltd. Consolidated 2021-03 30.53 299.00 +10.7%
Polo Queen Industrial & Fintech Ltd. Consolidated 2021-03 0.21 47.90 +0.5%
SIRCA Paints India Ltd. Consolidated 2021-03 8.59 439.15 -0.5%
Shankar Lal Rampal Dye-Chem Ltd. Standalone 2021-03 16.58 504.50 +3.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 39,537.13 2,161.50 +2.5%
Redington (India) Ltd. Consolidated 2021-03 56,945.86 121.85 +5.0%
MMTC Ltd. Consolidated 2021-03 30,001.47 39.75 +16.2%
Optiemus Infracom Ltd. Consolidated 2021-03 314.39 299.00 +10.7%
Polo Queen Industrial & Fintech Ltd. Consolidated 2021-03 32.11 47.90 +0.5%
SIRCA Paints India Ltd. Consolidated 2021-03 143.18 439.15 -0.5%
Shankar Lal Rampal Dye-Chem Ltd. Standalone 2021-03 177.58 504.50 +3.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 746.32 2,161.50 +2.5%
Redington (India) Ltd. Consolidated 2021-03 786.61 121.85 +5.0%
MMTC Ltd. Consolidated 2021-03 -790.07 39.75 +16.2%
Optiemus Infracom Ltd. Consolidated 2021-03 86.50 299.00 +10.7%
Polo Queen Industrial & Fintech Ltd. Consolidated 2021-03 0.33 47.90 +0.5%
SIRCA Paints India Ltd. Consolidated 2021-03 16.58 439.15 -0.5%
Shankar Lal Rampal Dye-Chem Ltd. Standalone 2021-03 7.63 504.50 +3.7%

FAQ's On EVOQ Remedies Ltd.

Can I Buy EVOQ Remedies Shares now?

What is the Share Price of EVOQ Remedies?

What is the Relative Strength Index (RSI) Value of EVOQ Remedies?

What is the Market Capital (MCAP) of EVOQ Remedies?

What are the key metrics to analyse EVOQ Remedies?

What is the Price Performance of EVOQ Remedies?